Laryngeal chondromas: Current knowledge and future directions.

chondroma laryngeal neoplasms larynx scoping review

Journal

Laryngoscope investigative otolaryngology
ISSN: 2378-8038
Titre abrégé: Laryngoscope Investig Otolaryngol
Pays: United States
ID NLM: 101684963

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 20 01 2024
revised: 17 04 2024
accepted: 25 04 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

Cartilaginous tumors of the larynx are rare, representing less than 1% of all laryngeal tumors. Chondromas are benign mesenchymal tumors characterized by a slow-paced growth, primarily originated in the cricoid cartilage, followed by the thyroid, arytenoid, and epiglottic cartilages. This scoping review aims to understand the extent of evidence on the epidemiology, clinical characteristics, morbidity, and recurrence of the laryngeal chondroma (LC). MEDLINE (Ovid), Embase (Elsevier), Web of Science (Clarivate), Cochrane Central Register of Controlled Trials and Systematic Reviews, Lilacs, Scopus, and Google Scholar databases. The scoping review was conducted from 1816 to 2023, for observational studies describing LC. Titles and abstracts were screened for relevance, followed by an evaluation of the full text for eligibility. The data were collected from the qualifying articles, and a narrative summary of the outcomes was prepared. One hundred and nineteen studies met the inclusion criteria. Ninety-four case reports, 22 case series, and 3 cohorts. Two hundred and four participants with a diagnosis of LC were described. Male:female ratio was 2.8:1. The most common localization was the cricoid (113; 47.08%), followed by the thyroid (45; 18.75%), and the arytenoid cartilage (27; 11.25%). Dyspnea (78.85%) and hoarseness (74.28%) were the most reported symptoms. The recurrence rate was 11.25%, and complications were uncommon following the resection. This scoping review found a low-frequency rate over all the cartilaginous laryngeal tumors. Most patients were treated with resection, with a low rate of malignancy conversion. This population has low attributable mortality, morbidity, and recurrence according to the current literature.

Identifiants

pubmed: 38835336
doi: 10.1002/lio2.1265
pii: LIO21265
pmc: PMC11149761
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e1265

Informations de copyright

© 2024 The Author(s). Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Estephania Candelo (E)

Department of Otorhinolaryngology Mayo Clinic Florida Jacksonville Florida USA.
Centro de Investigaciones Clinicas Fundacion Valle del Lili Cali Colombia.

Anyull D Bohorquez Caballero (AD)

Department of Otorhinolaryngology Mayo Clinic Florida Jacksonville Florida USA.

Jorge A Abello-Vaamonde (JA)

Facultad de Ciencias de la Salud Universidad Anáhuac Mexico Mexico City Mexico.

Ana Maria Sanz (AM)

Centro de Investigaciones Clinicas Fundacion Valle del Lili Cali Colombia.

Roberta Lozano Gonzalez (R)

Facultad de Ciencias de la Salud Universidad Anáhuac Mexico Mexico City Mexico.

Cynthia Chelf (C)

Mayo Clinic Libraries Rochester Minnesota USA.

Abigail M Williams (AM)

Florida State University Tallahassee Florida USA.

Amy L Rutt (AL)

Department of Otorhinolaryngology Mayo Clinic Florida Jacksonville Florida USA.

Classifications MeSH